JENNIFER MARTINEZ: Open Payments
NPI 1497179998 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,996 in 212 payments from 19 companies in 2025. Trend: 2023 $3,259 · 2024 $3,021 · 2025 $3,996
Food & beverage: $3,911Education: $85
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 38 | $566 |
| Janssen Biotech, Inc. | 27 | $499 |
| ABBVIE INC. | 27 | $480 |
| Lilly USA, LLC | 11 | $364 |
| Madrigal Pharmaceuticals | 14 | $353 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $316 |
| Aimmune Therapeutics, Inc. | 13 | $251 |
| PFIZER INC. | 11 | $187 |
| QOL Medical, LLC | 9 | $180 |
| Celltrion USA Inc. | 10 | $168 |
Products named: IQIRVO, TREMFYA, OMVOH, REZDIFFRA, XIFAXAN, MAVYRET, Sucraid, VEGZELMA.
Industry payments across TX — which companies pay providers there.
